Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb

International Journal of Medical Microbiology

Volumn 306, Issue 1, 2016, Pages 1-9

  Garg, Nisha ^a   Singh, Ravinder ^a   Shukla, Geeta ^a   Capalash, Neena ^a   Sharma, Prince ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Acinetobacter baumannii; Cytokines; Epitopes; Outer membrane nuclease; Reverse vaccinology; Vaccine

Indexed keywords

BACTERIAL VACCINE; INTERLEUKIN 10; INTERLEUKIN 6; NUCAB PROTEIN; NUCLEASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; DEOXYRIBONUCLEASE; EPITOPE; HLA ANTIGEN; OUTER MEMBRANE PROTEIN; RECOMBINANT VACCINE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BACTERIAL LOAD; BACTERIUM ISOLATE; COMPUTER MODEL; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMORAL IMMUNITY; INFLAMMATION; LUNG; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PROTEIN EXPRESSION; ACINETOBACTER INFECTIONS; ANIMAL; BAGG ALBINO MOUSE; BIOLOGY; BLOOD; CONSERVED SEQUENCE; CYTOCHEMISTRY; DISEASE MODEL; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MICROBIOLOGY; PATHOLOGY; PNEUMONIA, BACTERIAL; SURVIVAL ANALYSIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL LOAD; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; COMPUTATIONAL BIOLOGY; CONSERVED SEQUENCE; DEOXYRIBONUCLEASES; DISEASE MODELS, ANIMAL; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FEMALE; HISTOCYTOCHEMISTRY; HLA ANTIGENS; HUMANS; IMMUNIZATION, PASSIVE; LUNG; MICE, INBRED BALB C; PNEUMONIA, BACTERIAL; SURVIVAL ANALYSIS; VACCINES, SYNTHETIC;

EID: 84953255183     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2015.10.005     Document Type: Article

References (65)

1. Ariel N., Zvi A., Makarova K.S., Chitlaru T., Elhanany E., Velan B., Cohen S., Friedlander A.M., Shafferman A. Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens. Infect. Immun. 2003, 71:4563-4579.
2. Bailey T.L., Gribskov M. Combining evidence using p-values: application to sequence homology searches. Bioinformatics 1998, 14:48-54.
3. Baskar V., Madhan R., Srinivasan G., Selvakumar K., Radha M., Rajeshwari S. Identifying the potential tetravalent vaccine candidate for dengue virus using in silico approach. Insight Bioinform. 2011, 1:6-10.
4. Beavers S.F., Blossom D.B., Wiemken T.L., Kawaoka K.Y., Wong A., Goss L., McCormick M.I., Thoroughman D., Srinivasan A. Comparison of risk factors for recovery of Acinetobacter baumannii during outbreaks at two Kentucky hospitals, 2006. Public Health Rep. 2006, 124:868-884.
5. Bendjennat M., Blanchard A., Loutfi M., Montagnier L., Bahraoui E. Role of Mycoplasma penetrans endonuclease P40 as a potential pathogenic determinant. Infect. Immun. 1999, 67:4456-4462.
6. Bentancor L.V., O'Malley J.M., Bozkurt-Guzel C., Pier G.B., Maira-Litran T. Poly-N-Acetyl-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections. Infect. Immun. 2011, 80:651-656.
7. Bentancor L.V., Routray A., Bozkurt-Guzel C., Camacho-Peiro A., Pier G.B., Maira-Litrán T. Evaluation of the trimeric autotransporter Ata, as a vaccine candidate against Acinetobacter baumannii infections. Infect. Immun. 2012, 80:3381-3388.
8. Berends E.T.M., Horswill A.R., Haste N.M., Monestier M., Nizet V., von Kockritz-Blickwede M. Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil extracellular traps. J. Innate Immun. 2010, 2:576-586.
9. Betts J.C. Transcriptomics and proteomics: tools for the identification of novel drug targets and vaccine candidates for tuberculosis. IUBMB Life 2002, 53:239-242.
10. Bhargava N., Sharma P., Capalash N. N-acyl homoserine lactone mediated interspecies interactions between A. baumannii and P. aeruginosa. Biofouling 2012, 28:813-822.
11. Chang A., Khemlani A., Kang H., Proft T. Functional analysis of Streptococcus pyogenes nuclease A (SpnA), a novel group A streptococcal virulence factor. Mol. Microbiol. 2011, 79:1629-1642.
12. Chiang D.H., Wang C.C., Kuo H.Y., Chen H.P., Chen T.L., Wang F.D., Cho W.L., Liu C.Y. Risk factors for mortality in patients with Acinetobacter baumannii bloodstream infection with genotypic species identification. J. Microbiol. Immunol. Infect. 2008, 41:397-402.
13. Chiang M.H., Sung W.C., Lien S.P., Chen Y.Z., Lo A.F., Huang J.H., Kuo S.C., Chong P. Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology. Hum. Vaccines Immunother. 2015, 11:1065-1073.
14. Choi C.H., Lee J.S., Lee Y.C., Park T.I., Lee J.C. Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells. BMC Microbiol. 2008, 8:216.
15. Dagan R., Klugman K. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect. Dis. 2008, 8:785-795.
16. Davies M.N., Flower D.R. Harnessing bioinformatics to discover new vaccines. Drug Discov. Today 2007, 12:389-395.
17. de Groot A.S., Rappuoli R. Genome-derived vaccines. Expert Rev. Vaccines 2004, 3:59-76.
18. Falagas M.E., Rafailidis P.I., Matthaiou D.K., Virtzili S., Nikita D., Michalopoulos A. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients. Int. J. Antimicrob. Agents 2008, 32:450-454.
19. Fattahian Y., Rasooli I., Mousavi Gargari S.L., Rahbar M.R., Alipour Astaneh Darvish S., Amani J. Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap). Microb. Pathog. 2011, 51:402-406.
20. Fournier P.E., Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin. Infect. Dis. 2006, 42:692-699.
21. Gardy J.L., Laird M.R., Chen F., Rey S., Walsh C.J., Ester M., Brinkman F.S. PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics 2005, 21:617-623.
22. Goel V.K., Kapil A. Monoclonal antibodies against the iron regulated outer membrane proteins of Acinetobacter baumannii are bactericidal. BMC Microbiol. 2001, 1:16.
23. Gomez-Gascon L., Luque I., Olaya-Abril A., Jimenez-Munguia I., Orbegozo-Medina R.A., Peralbo E., Tarradas C., Rodríguez-Ortega M.J. Exploring the pan-surfome of Streptococcus suis: looking for common protein antigens. J. Proteomics 2012, 75:5654-5666.
24. Gordon N.C., Wareham D.W. A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline. J. Antimicrob. Chemother. 2009, 63:775-780.
25. Hasegawa T., Minami M., Okamoto A., Tatsuno I., Isaka M., Ohta M. Characterization of a virulent and cell-wall-located deoxyribonuclease of Streptococcus pyogenes. Microbiology 2010, 156:184-190.
26. Henikoff S., Henikoff J.G., Pietrokovski S. Blocks+: a non-redundant database of protein alignment blocks derived from multiple compilations. Bioinformatics 1999, 15:471-479.
27. Heun M., Binnenkade L., Kreienbaum M., Thormann K.M. Functional specificity of extracellular nucleases of Shewanella oneidensis MR-1. Appl. Environ. Microbiol. 2012, 78:4400-4411.
28. Higgins P.G., Dammhayn C., Hackel M., Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 2010, 65:233-238.
29. Huang W., Yao Y., Long Q., Yang X., Sun W., Liu C., Jin X., li Y., Chu X., Chen B., Ma Y. Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models. PLOS ONE 2014, 9:e100727.
30. Joice R., Lipsitch M. Targeting imperfect vaccines against drug-resistance determinants: a strategy for countering the rise of drug resistance. PLOS ONE 2013, 8:e68940.
31. Jones C.L., Clancy M., Honnold C., Singh S., Snesrud E., Onmus-Leone F., McGann P., Ong A.C., Kwak Y., Waterman P., Zurawski D.V., Clifford R.J., Lesho E. A fatal outbreak of an emerging clone of extensively drug-resistant Acinetobacter baumannii with enhanced virulence. Clin. Infect. Dis. 2015, 61:145-154.
32. Juneau R.A., Stevens J.S., Apicella M.A., Criss A.K. A thermonuclease of Neisseria gonorrhoeae enhances bacterial escape from killing by neutrophil extracellular traps. J. Infect. Dis. 2015, 212:316-324.
33. Käll L., Krogh A., Sonnhammer E.L. Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server. Nucleic Acids Res. 2007, 35:W429-W432.
34. Kumar M., Chakroborty S., Raina V., Kandpal U., Kumar M. Analysis of distribution of HLA class I antigens in population from six North Indian states. Apollo Med. 2007, 4:29-31.
35. Kuo L.C., Lai C.C., Liao C.H., Hsu C.K., Chang Y.L., Chang C.Y., Hsueh P.R. Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome. Clin. Microbiol. Infect. 2007, 13:196-198.
36. Li L., Stoeckert C.J., Roos D.S. OrthoMCL: identification of ortholog groups for eukaryotic genomes. Genome Res. 2003, 13:2178-2189.
37. Liechti G.W., Goldberg J.B. Helicobacter pylori salvages purines from extracellular host cell DNA utilizing the outer membrane-associated nuclease NucT. J. Bacteriol. 2013, 195:4387-4398.
38. Livermore D.M., Hill R.L., Thomson H., Charlett A., Turton J.F., Pike R., Patel B.C., Manuel R., Gillespie S., Balakrishnan I., Barrett S.P., Cumberland N., Twagira M. Antimicrobial treatment and clinical outcome for infections with carbapenem and multiply-resistant Acinetobacter baumannii around London. Int. J. Antimicrob. Agents 2010, 35:19-24. C-MRAB Study Group.
39. Luo G., Lin L., Ibrahim A.S., Baquir B., Pantapalangkoor P., Bonomo R.A., Doi Y., Adams M.D., Russo T.A., Spellberg B. Active and passive immunization protects against lethal, extreme drug-resistant Acinetobacter baumannii infection. PLoS ONE 2012, 7:e29446.
40. Mann E.E., Rice K.C., Boles B.R., Endres J.L., Ranjit D., Chandramohan L., Tsang L.H., Smeltzer M.S., Horswill A.R., Bayles K.W. Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PLoS ONE 2009, 4:e5822.
41. McConnell M.J., Dominguez-Herrera J., Smani Y., Lopez-Rojas R., Docobo-Perez F., Pachón J. Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii. Infect. Immun. 2010, 79:518-526.
42. McConnell M.J., Hanna P.C., Imperiale M.J. Cytokine response and survival of mice immunized with an adenovirus expressing Bacillus anthracis protective antigen domain 4. Infect. Immun. 2006, 74:1009-1015.
43. McConnell M.J., Pachón J. Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine. Vaccine 2010, 29:1-5.
44. McConnell M.J., Rumbo C., Bou G., Pachón J. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine 2011, 29:5705-5710.
45. Mehra N.K., Jaini R., Rajalingam R., Balamurugan A., Kaur G. Molecular diversity of HLA-A*02 in Asian Indians: predominance of A*0211. Tissue Antigens 2001, 57:502-507.
46. Moriel D.G., Beatson S.A., Wurpel D.J., Lipman J., Nimmo G.R., Paterson D.L., Schembri M.A. Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii. PLOS ONE 2013, 8:e77631.
47. Mulcahy H., Charron-Mazenod L., Lewenza S. Pseudomonas aeruginosa produces an extracellular deoxyribonuclease that is required for utilization of DNA as a nutrient source. Environ. Microbiol. 2010, 12:1621-1629.
48. O'Rourke E.J., Pinto A.V., Petroni E.A., Tolmasky M.E., Ielpi L. Evidence for the active role of a novel nuclease from Helicobacter pylori in the horizontal transfer of genetic information. J. Bacteriol. 2004, 186:2586-2593.
49. Peleg A.Y., de Breij A., Adams M.D., Cerqueira G.M., Mocali S., Galardini M., Nibbering P.H., Earl A.M., Ward D.V., Paterson D.L., Seifert H., Dijkshoorn L. The success of Acinetobacter species; genetic, metabolic and virulence attributes. PLoS ONE 2012, 7:e46984.
50. Pizza M., Scarlato V., Masignani V., Giuliani M.M., Arico B., Comanducci M., Jennings G.T., Baldi L., Bartolini E., Capecchi B., Galeotti C.L., Luzzi E., Manetti R., Marchetti E., Mora M., Nuti S., Ratti G., Santini L., Savino S., Scarselli M., Storni E., Zuo P., Broeker M., Hundt E., Knapp B., Blair E., Mason T., Tettelin H., Hood D.W., Jeffries A.C., Saunders N.J., Granoff D.M., Venter J.C., Moxon E.R., Grandi G., Rappuoli R. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000, 287:1816-1820.
51. Rajalingam R., Krausa P., Shilling H.G., Stein J.B., Balamurugan A., McGinnis M.D., Cheng N.W., Mehra N.K., Parham P. Distinctive KIR and HLA diversity in a panel North Indian Hindus. Imumunogenetics 2002, 53:1009-1019.
52. Rappuoli R. Reverse vaccinology, a genome-based approach to vaccine development. Vaccine 2001, 19:2688-2691.
53. Reid S.D., Green N.M., Sylva G.L., Voyich J.M., Stenseth E.T., DeLeo F.R., Palzkill T., Low D.E., Hill H.R., Musser J.M. Postgenomic analysis of four novel antigens of group a streptococcus: growth phase-dependent gene transcription and human serologic response. J. Bacteriol. 2002, 184:6316-6324.
54. Rosenthal V.D., Maki D.G., Jamulitrat S., Medeiros E.A., Todi S.K., Gomez D.Y., Leblebicioglu H., Abu Khader I., Miranda Novales M.G., Berba R., Ramírez Wong F.M., Barkat A., Pino O.R., Dueñas L., Mitrev Z., Bijie H., Gurskis V., Kanj S.S., Mapp T., Hidalgo R.F., Ben Jaballah N., Raka L., Gikas A., Ahmed A., Thu le T.A., Guzmán Siritt M.E. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am. J. Infect. Control 2010, 38:95-104. INICC Members.
55. Russo T.A., Beanan J.M., Olson R., MacDonald U., Cox A.D., St Michael F., Vinogradov E.V., Spellberg B., Luke-Marshall N.R., Campagnari A.A. The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization. Infect. Immun. 2013, 81:915-922.
56. Sachdeva G., Kumar K., Jain P., Ramachandran S. SPAAN: a software program for prediction of adhesions and adhesin-like proteins using neural networks. Bioinformatics 2005, 21:483-491.
57. Seper A., Fengler V.H.I., Roier S., Wolinski H., Kohlwein S.D., Bishop A.L., Camilli A., Reidl J., Schild S. Extracellular nucleases and extracellular DNA play important roles in Vibrio cholerae biofilm formation. Mol. Microbiol. 2011, 82:1015-1037.
58. Seper A., Hosseinzadeh A., Gorkiewicz G., Lichtenegger S., Roier S., Leitner D.R., Röhm M., Grutsch A., Reidl J., Urban C.F., Schild S. Vibrio cholerae evades neutrophil extracellular traps by the activity of two extracellular nucleases. PLoS Pathog. 2013, 9:e1003614.
59. Steichen C.T., Cho C., Shao J.Q., Apicella M.A. The Neisseria gonorrhoeae biofilm matrix contains DNA and an endogenous nuclease controls its incorporation. Infect. immun. 2011, 79:1504-1511.
60. Uchiyama S., Andreoni F., Schuepbach R.A., Nizet V., Zinkernagel A.S. DNase Sda1 allows invasive M1T1 group A Streptococcus to prevent TLR9-dependent recognition. PLoS Pathog. 2012, 8:e1002736.
61. van Faassen H., KuoLee R., Harris G., Zhao X., Conlan J.W., Chen W. Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice. Infect. Immun. 2007, 75:5597-5608.
62. Wachter K. Step Aside, MRSA, Here Comes Acinetobacter 2006, Ob. Gyn. News.
63. Wizemann T.M., Heinrichs J.H., Adamou J.E., Erwin A.L., Kunsch C., Choi G.H., Barash S.C., Rosen C.A., Masure H.R., Tuomanen E., Gayle A., Brewah Y.A., Walsh W., Barren P., Lathigra R., Hanson M., Langermann S., Johnson S., Koenig S. Use of whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect. Immun. 2001, 69:1593-1598.
64. Xiang Z., He Y. Vaxign: a web-based vaccine target design program for reverse vaccinology. Procedia Vaccinol. 2009, 1:23-29.
65. Zhang P., Summer W.R., Bagby G.J., Nelson S. Innate immunity and pulmonary host defense. Immunol. Rev. 2000, 173:39-51.